Meganhong11 (Talk | contribs) m |
|||
Line 384: | Line 384: | ||
<i style="font-size:14px;"> pLac-ClpXP-CI design </i></center> | <i style="font-size:14px;"> pLac-ClpXP-CI design </i></center> | ||
<br> | <br> | ||
− | This year, we improved upon the characterization of pLac-ClpXP-CI (part number BBa_KK1911001), a part submitted by Lambert’s 2016 iGEM team. pLac-ClpXP-CI is the third part of our inducible construct, and codes for ClpXP, a non-lysosomal protein degradationn system, and CI, a competitive inhibitor that, once expressed, inhibits further transcription of p-lambda-rLacI tsPurple. Last year, there was an error in the submitted sequence where the beginning of the construct was omitted from the parts registry page. This year’s team recognized the problem and fully sequenced pLac-ClpXP-CI to determine the correct sequence. We began by sequencing with VF2 and VR, however since pLac-ClpXP-CI is almost 3000 base pairs long, the initial sequencing did not capture the middle part of the sequence. To fix this problem, primers were designed to capture the middle thousand base pairs; the results of this sequencing confirmed the middle part of the construct. After comparing this year’s sequencing results to last year’s submitted part, the team realized there was a double terminator at the beginning of the sequence, which would stop transcription from p-lambda-r | + | This year, we improved upon the characterization of pLac-ClpXP-CI (part number BBa_KK1911001), a part submitted by Lambert’s 2016 iGEM team. pLac-ClpXP-CI is the third part of our inducible construct, and codes for ClpXP, a non-lysosomal protein degradationn system, and CI, a competitive inhibitor that, once expressed, inhibits further transcription of p-lambda-rLacI tsPurple. Last year, there was an error in the submitted sequence where the beginning of the construct was omitted from the parts registry page. This year’s team recognized the problem and fully sequenced pLac-ClpXP-CI to determine the correct sequence. We began by sequencing with VF2 and VR, however since pLac-ClpXP-CI is almost 3000 base pairs long, the initial sequencing did not capture the middle part of the sequence. To fix this problem, primers were designed to capture the middle thousand base pairs; the results of this sequencing confirmed the middle part of the construct. After comparing this year’s sequencing results to last year’s submitted part, the team realized there was a double terminator at the beginning of the sequence, which would stop transcription from p-lambda-r LacI tsPurple, the earlier part of the construct. In light of this information, the parts registry page from last year was updated for clarity on the full construct design. |
<br><br> | <br><br> | ||
</p> | </p> |
Revision as of 13:06, 1 November 2017
Updated Parts
![](https://static.igem.org/mediawiki/2017/b/bc/T--Lambert_GA--purpleline.png)
![](https://static.igem.org/mediawiki/2017/2/2d/R0011clpxpcidiagram.png)
pLac-ClpXP-CI design
This year, we improved upon the characterization of pLac-ClpXP-CI (part number BBa_KK1911001), a part submitted by Lambert’s 2016 iGEM team. pLac-ClpXP-CI is the third part of our inducible construct, and codes for ClpXP, a non-lysosomal protein degradationn system, and CI, a competitive inhibitor that, once expressed, inhibits further transcription of p-lambda-rLacI tsPurple. Last year, there was an error in the submitted sequence where the beginning of the construct was omitted from the parts registry page. This year’s team recognized the problem and fully sequenced pLac-ClpXP-CI to determine the correct sequence. We began by sequencing with VF2 and VR, however since pLac-ClpXP-CI is almost 3000 base pairs long, the initial sequencing did not capture the middle part of the sequence. To fix this problem, primers were designed to capture the middle thousand base pairs; the results of this sequencing confirmed the middle part of the construct. After comparing this year’s sequencing results to last year’s submitted part, the team realized there was a double terminator at the beginning of the sequence, which would stop transcription from p-lambda-r LacI tsPurple, the earlier part of the construct. In light of this information, the parts registry page from last year was updated for clarity on the full construct design.